Results 211 to 220 of about 74,341 (223)

A Phase II Trial of Imatinib (ST1571) in Patients With c-Kit Expressing Relapsed Small-Cell Lung Cancer: A CALGB and NCCTG Study

Annals of Oncology, 2005
Steven E Schild, A A Miller, J R Jett
exaly  

Two-Stage Phase II Study of Imatinib Mesylate in Subjects With Refractory or Relapsing Neuroblastoma

Annals of Oncology, 2013
Marta Podda, Alberto Garaventa, Roberto Luksch   +2 more
exaly  

Process of preparing imatinib and imatinib prepared thereby

2004
KANKAN RAJENDRA NARAYANRAO, RAO DHARMARAJ RAMACHANDRA   +1 more
openaire   +2 more sources

Survival of Patients With Chronic-Phase Chronic Myeloid Leukaemia on Imatinib After Failure on Interferon Alfa

Lancet, The, 2003
David Marin, Richard Szydlo, Eduardo Olavarría   +2 more
exaly  

Imatinib

Reactions Weekly, 2018
openaire   +2 more sources

Clinical and Prognostic Significance of Histamine Monitoring in Patients With CML During Treatment With Imatinib (STI571)

Annals of Oncology, 2007
Christine Mannhalter, Hermann Agis, W R Sperr   +2 more
exaly  

Report of an International Expanded Access Program of Imatinib in Adults With Philadelphia Chromosome Positive Leukemias

Annals of Oncology, 2008
J M Ford
exaly  

Imatinib

Reactions Weekly, 2006
openaire   +1 more source

Phase III Study of Nilotinib Versus Best Supportive Care With or Without a TKI in Patients With Gastrointestinal Stromal Tumors Resistant to or Intolerant of Imatinib and Sunitinib

Annals of Oncology, 2012
Jean-Yves Blay, Hans J. Gelderblom, Y Hsu   +2 more
exaly  

Influence of Enzyme and Transporter Polymorphisms on Trough Imatinib Concentration and Clinical Response in Chronic Myeloid Leukemia Patients

Annals of Oncology, 2013
Jooseop Chung, Joon-Ho Moon, C W Jung
exaly